Using a mouse model, Dr. Auer and her team showed that an influenza vaccine, administered intravenously just prior to cancer surgery, could stimulate certain cancer-fighting immune cells (called natural killer cells), and reduce subsequent spread of the cancer by 50-80%. They also demonstrated stimulation of these natural killer cells in human volunteers receiving a flu vaccine as part of the TOH vaccination campaign, suggesting that this strategy could also work in patients. The results are published in Clinical Cancer Research.
Funders: Canadian Cancer Society Research Institute, Ontario Ministry of Research and Innovation, Fonds de recherche du Québec – Santé, Ottawa Hospital Foundation
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 ext. 73325